Prescription Drugs - Laos

  • Laos
  • The Prescription Drugs market in Laos is expected to witness a significant growth in revenue, reaching a projected value of US$17.78m in 2024.
  • This growth is anticipated to continue at a compound annual growth rate (CAGR 2024-2029) of 0.25%, resulting in a market volume of US$18.00m by 2029.
  • When compared globally, it is noteworthy that United States will generate the highest revenue in this market, with an estimated value of US$358.90bn in 2024.
  • However, in terms of per capita revenue, in Laos generates approximately US$2.30 per person in 2024.
  • Laos is experiencing an increasing demand for prescription drugs due to the rising prevalence of chronic diseases.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Laos has been experiencing steady growth in recent years. Customer preferences in the Prescription Drugs (Pharmacies) market in Laos have been shifting towards increased access to healthcare services and a greater demand for prescription medications. As the population in Laos continues to grow and age, there is a greater need for healthcare services, including the availability of prescription drugs. Additionally, there has been a growing awareness and understanding of the importance of proper medication management and adherence to prescribed treatments. Trends in the Prescription Drugs (Pharmacies) market in Laos include the expansion of pharmacy chains and the increasing availability of over-the-counter medications. As the demand for prescription drugs continues to rise, pharmacy chains have been expanding their operations to meet the needs of the growing population. This expansion has led to increased competition in the market, which has resulted in lower prices and improved access to prescription medications for consumers. Additionally, the availability of over-the-counter medications has also increased, providing consumers with more options for self-treatment of common ailments. Local special circumstances in Laos, such as the limited access to healthcare services in rural areas, have also contributed to the growth of the Prescription Drugs (Pharmacies) market. In many rural areas of Laos, there is a lack of healthcare facilities and trained medical professionals. As a result, pharmacies have become an important source of healthcare services, providing access to prescription medications and basic healthcare advice. This has led to an increase in the number of pharmacies in these areas and a greater reliance on pharmacies for healthcare needs. Underlying macroeconomic factors, such as the overall economic growth and increasing disposable income in Laos, have also played a role in the development of the Prescription Drugs (Pharmacies) market. As the economy in Laos continues to grow, there is a greater ability for consumers to afford healthcare services and prescription medications. This has led to an increase in demand for prescription drugs and the expansion of the market to meet this demand. Additionally, the government of Laos has also taken steps to improve access to healthcare services, including the availability of prescription medications, which has further supported the growth of the market. In conclusion, the Prescription Drugs (Pharmacies) market in Laos is developing due to changing customer preferences, including increased access to healthcare services and a greater demand for prescription medications. This is supported by trends such as the expansion of pharmacy chains and the increasing availability of over-the-counter medications. Local special circumstances, such as limited access to healthcare services in rural areas, and underlying macroeconomic factors, including economic growth and increasing disposable income, have also contributed to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)